Format

Send to

Choose Destination
Nat Immunol. 2010 Nov;11(11):975-8. doi: 10.1038/ni1110-975.

A model for harmonizing flow cytometry in clinical trials.

Author information

1
Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, California, USA. maecker@stanford.edu

Erratum in

  • Nat Immunol. 2010 Nov;11(11):979. DiMeglio, Paola [corrected to Di Meglio, Paola]; Nestle, Frank [corrected to Nestle, Frank O]; Villnova, Federica [corrected to Villanova, Federica].
  • Nat Immunol. 2011 Mar;12(3):271.

Abstract

Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.

PMID:
20959798
PMCID:
PMC3400260
DOI:
10.1038/ni1110-975
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center